PT  - JOURNAL ARTICLE
AU  - Wang, Yifei
AU  - Peng, Hao (Michael)
AU  - Sha, Long
AU  - Liu, Zheyuan
AU  - Hong, Pengyu
TI  - State-level COVID-19 Trend Forecasting Using Mobility and Policy Data
AID  - 10.1101/2021.01.04.21249218
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.04.21249218
4099  - http://medrxiv.org/content/early/2021/01/06/2021.01.04.21249218.short
4100  - http://medrxiv.org/content/early/2021/01/06/2021.01.04.21249218.full
AB  - The importance of pandemic forecast cannot be overemphasized. We propose an interpretable machine learning approach for forecasting pandemic transmission rates by utilizing local mobility statistics and government policies. A calibration step is introduced to deal with time-varying relationships between transmission rates and predictors. Experimental results demonstrate that our approach is able to make accurate two-week ahead predictions of the state-level COVID-19 infection trends in the US. Moreover, the models trained by our approach offer insights into the spread of COVID-19, such as the association between the baseline transmission rate and the state-level demographics, the effectiveness of local policies in reducing COVID-19 infections, and so on. This work provides a good understanding of COVID-19 evolution with respect to state-level characteristics and can potentially inform local policymakers in devising customized response strategies.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNoFunding StatementThis work was partially supported by NSF OAC 1920147.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in this manuscript. https://github.com/nytimes/covid-19-data https://data.bts.gov/Research-and-Statistics/Trips-by-Distance/w96p-f2qv https://github.com/yifeiwang15/COVID-19-Mobility/tree/main/data